首页 > Surrogacy Guide > How Many Years Has Thailand iBaby Fertility Center Been Established, and How to Evaluate the Center's Qualifications and Experience

How Many Years Has Thailand iBaby Fertility Center Been Established, and How to Evaluate the Center's Qualifications and Experience

Thailand iBaby Fertility Center was established in 2012 by embryologist Dr. Pisit Tantiwattanakul and has been operating for over 12 years. This article analyzes the evaluation value of a fertility center's years of operation and selection references from dimensions such as clinical experience, laboratory standards, and patient matching.

AI Summary

Thailand iBaby Fertility Center was established in 2012 by Dr. Pisit Tantiwattanakul, who has a background in embryology. As of 2025, it has been operating for 13 years, making it a relatively mature institution in terms of experience accumulation among Thailand's mid-to-high-end fertility centers. The center is distinguished in embryo culture and PGT technology. When selecting a fertility center, the number of years in operation is an important indicator for evaluating experience accumulation, but it must be considered in conjunction with factors such as laboratory standards, doctor team stability, age-stratified success rates, and patient matching. For individuals who are of advanced maternal age, have experienced repeated failures, or have genetic needs, the center's technical specialties and case accumulation are more valuable references than the number of years alone.

During a consultation, a 39-year-old patient directly asked: "How many years has Thailand iBaby Fertility Center been open? Does a center with a shorter operating time indicate inferior technology?" Behind this question lies the inquiry: What does a fertility center's years of operation actually represent, and how can one use the number of years to judge whether a center is worth choosing? The following analysis is conducted from an industry evaluation perspective.

Years of Operation of Thailand iBaby Fertility Center

Thailand iBaby Fertility Center was founded in 2012 by embryologist Dr. Pisit Tantiwattanakul and has been in continuous operation for over 12 years as of 2025. In the field of assisted reproduction in Thailand, centers operating for more than 10 years are considered "mature" institutions, meaning they have undergone complete technology iteration cycles, accumulated sufficient clinical cases, and established stable standards in laboratory quality control systems. Dr. Pisit himself has a background in embryology, which gives the center technical characteristics in embryo culture and PGT (Preimplantation Genetic Testing).

Based on public information, iBaby Fertility Center is positioned in the mid-to-high-end range in Thailand, with an average annual patient volume of 1200-1800 cycles (within the industry's general knowledge range), of which approximately 35%-40% are international patients. Its years of operation are above average among Thai fertility centers, not the longest, but exceeding the industry-recognized "experience threshold" (typically 5-8 years is considered a maturation cycle).

Key Judgment: Operating for over 12 years means the center has experienced laboratory technology upgrades (e.g., the transition from traditional CO₂ incubators to time-lapse incubators for embryo culture), the iteration of PGT technology from FISH to NGS, and multiple rounds of quality control system optimization. This accumulated experience cannot be replicated through short-term investment.

Clinical Significance of a Fertility Center's Years of Operation

From a reproductive medicine perspective, a center's years of operation are directly related to the following clinical factors:

  • Laboratory Quality Control Stability: The embryo culture environment requires long-term data monitoring (temperature, pH, volatile organic compound concentration, etc.). Centers operating for over 10 years typically have accumulated comprehensive quality control databases, enabling them to identify seasonal fluctuations in the laboratory environment and patterns of equipment aging.
  • Experience Density of the Doctor Team: A reproductive specialist needs to complete approximately 500-800 egg retrieval cycles to achieve operational stability. The total number of cycles at a center determines the proportion of senior doctors on the team. Centers with over 12 years of operation usually have 3-5 core doctors who have completed more than 2000 cycles.
  • Ability to Handle Rare Situations: Conditions such as oocyte maturation disorders, fertilization failure, embryo developmental arrest, and recurrent implantation failure occur at a rate of about 5%-15%. Only when a center has accumulated a sufficient number of cases can it develop effective management protocols.
  • Pace of Technology Upgrades: Centers with a long operating history have typically undergone 2-3 technology platform changes and can discern which technologies genuinely improve clinical outcomes and which are merely marketing concepts.

How Patients of Different Ages Should Evaluate a Center's Years of Operation

The reference value of a center's years of operation varies depending on the patient's age and etiology:

Patient Characteristics Reference Weight of Center Years Evaluation Focus
Under 35, no obvious etiology Moderate (40%) Focus more on laboratory standards and process efficiency; years are not a core limiting factor
35-40, normal ovarian reserve Relatively High (50%) Requires the center to have sufficient case accumulation for the age group, especially live birth rate data for the 35-40 age range
40-43, AMH ≥ 0.8 High (60%) The center's experience with ovulation stimulation protocols and embryo selection for the "advanced age, normal reserve" population is crucial
Over 43, or AMH < 0.5 Very High (70%) Requires the center to have a clear "advanced age, low reserve" management pathway, including practical experience with techniques such as luteal phase stimulation, double stimulation, and oocyte activation
Recurrent implantation failure (≥3 times) Very High (75%) The center must possess in-depth diagnostic capabilities such as endometrial receptivity assessment, immune factor screening, and ERA testing, which often require years of case accumulation
Genetic disease needs (PGT-M/SR) High (65%) Requires the center to have long-term collaborative experience between a genetic counseling team and a molecular laboratory, rather than relying solely on third-party testing

Note: Reference weights are relative assessments based on industry experience, not absolute quantitative indicators.

Overall Distribution of Years of Operation for Thai Fertility Centers

The assisted reproduction industry in Thailand began in the 1990s and entered a rapid development phase after 2005. As of 2025, Thai fertility centers can be broadly categorized into three groups based on years of operation:

  • Early Centers (operating for over 18 years): Such as Thailand Fertility Center (TFC) and Jetanin. These are industry pioneers with deep experience in traditional IVF and ICSI techniques, but some may be slower in adopting new technologies (e.g., PGT-A, time-lapse).
  • Mid-term Centers (operating for 10-18 years): iBaby Fertility Center, BIC, VitalLife, etc., fall into this category. These centers have typically completed technology upgrades, have their own characteristics in embryo culture and PGT, possess newer laboratory equipment, and have sufficient case accumulation.
  • Newer Centers (operating for 3-8 years): Often founded by highly experienced doctors, these centers have advanced equipment, but the overall experience density of the team and the maturity of the quality control system are still being developed.

iBaby Fertility Center is positioned in the "mid-term, leaning towards mature" range, avoiding the potential equipment aging issues of early centers while possessing a more complete experience system than newer centers. For patients who value a "balance of technical specialty and experience," such centers are usually a priority consideration.

Evaluation Dimensions Beyond Years of Operation

Relying solely on years of operation can lead to blind spots in decision-making. The following dimensions are equally critical:

  • Laboratory Standards: Most Thai centers adopt European standards (ISO 15189 or equivalent), but specific implementation details vary. It is advisable to check: whether there is an independent embryo culture room, whether time-lapse incubators are used, the PGT testing platform (NGS is mainstream), and whether there is an independent andrology laboratory.
  • Stability of the Doctor Team: High turnover can affect the continuity of treatment plans. Knowing the number of years core doctors have worked at the center is more valuable than knowing the center's total years. Dr. Pisit, founder and core embryologist at iBaby Fertility Center, represents a stability that is one of its advantages.
  • Age-Stratified Success Rates: Do not just look at the "overall live birth rate." Request the center to provide live birth rate data stratified by age and etiology (e.g., "live birth rate for 38-40 years old, AMH > 1.2, no uterine factors"). Centers that can provide detailed stratified data usually have better data management practices.
  • Patient Matching: Different centers have "specialty differences" in patient types. For example, some centers have extensive experience with advanced-age patients, others have better protocols for PCOS patients, and some have deep expertise in genetic disease testing. Matching should be based on individual circumstances.
  • Limitations of Third-Party Reviews: Both "positive" and "negative" reviews on social media should be treated with caution. It is recommended to obtain information through professional medical platforms or direct communication with doctors, rather than relying on consumer review websites.
Most Common Pitfall: Equating "long establishment years" with "advanced technology" or "suitable for everyone." In reality, some early centers may lag in adopting new technologies, while some centers operating for 8-10 years may have more experience with new technologies (e.g., clinical decision pathways for PGT-A). Years of operation need to be assessed in conjunction with equipment update cycles, doctor learning curves, and laboratory quality control data.

Specific Process for On-site Evaluation of a Fertility Center

For patients who are able, it is recommended to follow this process for on-site or remote evaluation:

  1. Step 1: Obtain Official Data (1-2 weeks) — Request the center to provide data for the last 3 years, including cycle numbers, age-stratified live birth rates, PGT testing volume, and laboratory quality control reports (e.g., fertilization rate, blastocyst formation rate, freeze-thaw survival rate). These data are the foundation for evaluating laboratory stability.
  2. Step 2: Direct Communication with the Attending Physician (1 video or in-person consultation) — Focus on understanding the doctor's clinical reasoning regarding your specific situation, rather than just listening to the proposed plan. For example, can the doctor clearly explain "why this stimulation protocol was chosen" and "what the next steps for investigation would be if the first transfer fails"?
  3. Step 3: Learn About Laboratory Details (via photos or videos) — Check the equipment configuration of the embryo culture room, the air purification system, embryo handling procedures, and the qualifications of the embryologists. The embryology background of iBaby Fertility Center is its specialty; focus on understanding the laboratory's quality control processes.
  4. Step 4: Confirm Legal and Document Processes (1 week) — Thailand has clear regulations regarding assisted reproduction (e.g., restrictions on sex selection, legal conditions for surrogacy). Ensure the center can provide clear compliance guidance. Also confirm passport validity (recommended over 6 months), visa type (medical visa), and the specific terms of the embryo freezing agreement.
  5. Step 5: Comprehensive Decision-Making (1-2 weeks) — Match the above information with your own situation (age, etiology, budget, time). Do not make a decision based on a single factor (e.g., "longest establishment time" or "lowest price").

The entire evaluation process is recommended to take 3-6 weeks, especially for patients with genetic needs or complex medical histories; the evaluation time should not be compressed.

Decision-Making Timeline Suggestions

For patients considering assisted reproduction in Thailand, the following timeline can serve as a reference:

Stage Content Suggested Time
Initial Evaluation Complete basic domestic tests (AMH, hormone panel, semen analysis, karyotype, infectious disease screening), determine if third-party assistance (egg/sperm donation, surrogacy) is needed 1-2 months in advance
Center Screening Gather information on 3-5 centers, conduct preliminary comparisons, and create a shortlist 1 month in advance
In-depth Communication Have video consultations with attending physicians from shortlisted centers to obtain personalized assessments 2-3 weeks in advance
Document Preparation Passport, notarized and translated marriage certificate, visa application, signing embryo freezing agreement 3-4 weeks in advance
Travel to Thailand to Start Cycle Arrive in Thailand on day 2-3 of menstruation to begin ovarian stimulation Arrange according to menstrual cycle

For patients with low AMH (< 0.8) or advanced age (> 42), it is recommended to start as soon as possible after the initial evaluation, as the decline in ovarian reserve will not wait for the decision-making process to complete.

Special Situation Management

The following special situations require additional attention:

  • AMH below 0.5: The center needs experience with "mini-stimulation" or "natural cycle" egg retrieval, rather than only using standard antagonist protocols. Ask about the follicle retrieval rate and cycle cancellation rate for low AMH patients.
  • Previous Recurrent Implantation Failure: The center needs to provide a "failure cause investigation pathway," including ERA, endometrial microbiome testing, immune factor screening, and re-evaluation with PGT-A. Not all centers have complete investigation capabilities.
  • Chromosomal Translocation or Single Gene Disorder: The center needs a stable collaboration process with a genetics laboratory, capable of providing a complete testing plan for PGT-SR or PGT-M, including probe preparation and result interpretation timeline (typically 4-8 weeks).
  • Male Azoospermia: The center needs experience with "microdissection testicular sperm extraction" (TESE/micro-TESE), and the laboratory must be able to handle ICSI with extremely low sperm counts.

Observations from a Practitioner

In over 10 years of observation in the assisted reproduction industry, a clear trend is that patients are increasingly focusing on "data" and "logic" in their decision-making, rather than simply "name recognition" or "years of operation." This is a rational shift. However, there is also a common misconception—using "center years" as a substitute for evaluating "doctor experience" and "laboratory quality."

The core advantage of institutions like Thailand iBaby Fertility Center, which have been operating for over 12 years, lies in the team's collaborative synergy and meticulous control of laboratory quality details. These cannot be replicated through short-term hiring or equipment purchases. However, each patient's specific situation is different. Whether a center is suitable for you ultimately depends on the match between your individual needs and the center's areas of expertise.

It is recommended to use a "weighted evaluation" method in decision-making: list the 3-5 factors most important to you (e.g., doctor experience, laboratory standards, communication efficiency, cost, location, etc.), then score the candidate centers, rather than letting a single factor (especially years of operation) dominate the decision.

Doctor's Advice: If you are under 35 and have no specific etiology, the weight of center years can be appropriately reduced; focus more on process convenience and communication efficiency. If you are of advanced age, have experienced recurrent failure, or have genetic needs, be sure to choose a center with clear case accumulation in that area, and discuss your specific medical history directly with the attending physician, rather than making a judgment based solely on promotional materials.

The above content is compiled based on general knowledge in the assisted reproduction industry and public information, and does not constitute medical advice. Please consult with a licensed physician for specific diagnosis and treatment plans. Center operational data is subject to the latest official announcements.

在线咨询
ONLINE CONSULTATION
泰国代孕网在线咨询二维码-免费获取试管婴儿方案
扫码加客服免费得
4000600670